Education
About Us
Working with TipRanks
Follow Us
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 105.76M | $ 113.45M | $ 102.29M | $ 7.34M | $ 20.95M |
| Gross Profit | $ 101.87M | $ 108.81M | $ 97.50M | $ -332.00K | $ 11.79M |
| Operating Income | $ 16.16M | $ -67.23M | $ 9.20M | $ -83.73M | $ -57.37M |
| EBITDA | $ 17.82M | $ 20.33M | $ 10.33M | $ -87.64M | $ -56.10M |
| Net Income | $ 12.09M | $ -92.93M | $ 2.30M | $ -87.93M | $ -55.54M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 26.67M | $ 33.51M | $ 25.18M | $ 46.85M | $ 79.35M |
| Total Assets | $ 125.41M | $ 116.54M | $ 84.75M | $ 55.66M | $ 94.85M |
| Total Debt | $ 1.60M | $ 409.00K | $ 613.00K | $ 2.38M | $ 1.64M |
| Net Debt | $ -10.21M | $ -33.10M | $ -24.56M | $ -41.96M | $ -28.72M |
| Total Liabilities | $ 27.00M | $ 102.59M | $ 12.54M | $ 14.57M | $ 18.78M |
| Stockholders' Equity | $ 63.32M | $ -15.83M | $ 42.52M | $ 41.09M | $ 76.07M |
| Cash Flow | |||||
| Free Cash Flow | $ -6.77M | $ 17.31M | $ 5.68M | $ -84.59M | $ -55.31M |
| Operating Cash Flow | $ -3.64M | $ 25.89M | $ 10.68M | $ -83.75M | $ -55.05M |
| Investing Cash Flow | $ -19.88M | $ -19.76M | $ -13.81M | $ 48.19M | $ 9.66M |
| Financing Cash Flow | $ 2.10M | $ 2.50M | $ 0.00 | $ 49.55M | $ 60.38M |